Clinical practice guidelines for the prevention and treatment of osteoporosis in Taiwan: 2022 update

Ta Wei Tai; Chun Feng Huang; Huei Kai Huang; Rong Sen Yang; Jung Fu Chen; Tien Tsai Cheng; Fang Ping Chen; Chung Hwan Chen; Yin Fan Chang; Wei Chieh Hung; Der Sheng Han; Ding Cheng Chan; Ching Chou Tsai; I. Wen Chen; Wing P. Chan; Husan Jui Chang; Jawl Shan Hwang; Chih Hsing Wu

doi:10.1016/j.jfma.2023.01.007

Clinical practice guidelines for the prevention and treatment of osteoporosis in Taiwan: 2022 update

Ta Wei Tai, Chun Feng Huang, Huei Kai Huang, Rong Sen Yang, Jung Fu Chen, Tien Tsai Cheng, Fang Ping Chen, Chung Hwan Chen, Yin Fan Chang, Wei Chieh Hung, Der Sheng Han, Ding Cheng Chan, Ching Chou Tsai, I. Wen Chen, Wing P. Chan, Husan Jui Chang, Jawl Shan Hwang, Chih Hsing Wu

Research output: Contribution to journal › Review article › peer-review

19 Citations (Scopus)

Abstract

Osteoporosis greatly increases the risk of fractures. Osteoporotic fractures negatively impact quality of life, increase the burden of care, and increase mortality. Taiwan is an area with a high prevalence of osteoporosis. This updated summary of guidelines has been developed by experts of the Taiwan Osteoporosis Association with the intention of reducing the risks of osteoporotic fractures and improving the quality of care for patients with osteoporosis. The updated guidelines compile the latest evidence to provide clinicians and other healthcare professionals with practical recommendations for the prevention, diagnosis, and management of osteoporosis under clinical settings in Taiwan.

Original language	English
Pages (from-to)	S4-S13
Journal	Journal of the Formosan Medical Association
Volume	122
Issue number	Suppl 1
DOIs	https://doi.org/10.1016/j.jfma.2023.01.007
Publication status	Published - 2023

Keywords

Bone Density Conservation Agents/therapeutic use
Humans
Osteoporosis/complications
Osteoporotic Fractures/prevention & control
Quality of Life
Secondary Prevention
Taiwan/epidemiology

Access to Document

10.1016/j.jfma.2023.01.007

Cite this

Tai, T. W., Huang, C. F., Huang, H. K., Yang, R. S., Chen, J. F., Cheng, T. T., Chen, F. P., Chen, C. H., Chang, Y. F., Hung, W. C., Han, D. S., Chan, D. C., Tsai, C. C., Chen, I. W., Chan, W. P., Chang, H. J., Hwang, J. S., & Wu, C. H. (2023). Clinical practice guidelines for the prevention and treatment of osteoporosis in Taiwan: 2022 update. Journal of the Formosan Medical Association, 122 (Suppl 1), S4-S13. https://doi.org/10.1016/j.jfma.2023.01.007

Tai, TW, Huang, CF, Huang, HK, Yang, RS, Chen, JF, Cheng, TT, Chen, FP, Chen, CH, Chang, YF, Hung, WC, Han, DS, Chan, DC, Tsai, CC, Chen, IW, Chan, WP, Chang, HJ, Hwang, JS & Wu, CH 2023, 'Clinical practice guidelines for the prevention and treatment of osteoporosis in Taiwan: 2022 update', Journal of the Formosan Medical Association, vol. 122 , no. Suppl 1, pp. S4-S13. https://doi.org/10.1016/j.jfma.2023.01.007

@article{6568ce0816e24cf2bbdf9c031dbcb677,

title = "Clinical practice guidelines for the prevention and treatment of osteoporosis in Taiwan: 2022 update",

abstract = "Osteoporosis greatly increases the risk of fractures. Osteoporotic fractures negatively impact quality of life, increase the burden of care, and increase mortality. Taiwan is an area with a high prevalence of osteoporosis. This updated summary of guidelines has been developed by experts of the Taiwan Osteoporosis Association with the intention of reducing the risks of osteoporotic fractures and improving the quality of care for patients with osteoporosis. The updated guidelines compile the latest evidence to provide clinicians and other healthcare professionals with practical recommendations for the prevention, diagnosis, and management of osteoporosis under clinical settings in Taiwan.",

keywords = "Bone Density Conservation Agents/therapeutic use, Humans, Osteoporosis/complications, Osteoporotic Fractures/prevention & control, Quality of Life, Secondary Prevention, Taiwan/epidemiology",

author = "Tai, {Ta Wei} and Huang, {Chun Feng} and Huang, {Huei Kai} and Yang, {Rong Sen} and Chen, {Jung Fu} and Cheng, {Tien Tsai} and Chen, {Fang Ping} and Chen, {Chung Hwan} and Chang, {Yin Fan} and Hung, {Wei Chieh} and Han, {Der Sheng} and Chan, {Ding Cheng} and Tsai, {Ching Chou} and Chen, {I. Wen} and Chan, {Wing P.} and Chang, {Husan Jui} and Hwang, {Jawl Shan} and Wu, {Chih Hsing}",

note = "Copyright {\textcopyright} 2023. Published by Elsevier B.V.",

year = "2023",

doi = "10.1016/j.jfma.2023.01.007",

language = "English",

volume = "122 ",

pages = "S4--S13",

journal = "Journal of the Formosan Medical Association",

issn = "0929-6646",

publisher = "Elsevier B.V.",

number = "Suppl 1",

}

TY - JOUR

T1 - Clinical practice guidelines for the prevention and treatment of osteoporosis in Taiwan

T2 - 2022 update

AU - Tai, Ta Wei

AU - Huang, Chun Feng

AU - Huang, Huei Kai

AU - Yang, Rong Sen

AU - Chen, Jung Fu

AU - Cheng, Tien Tsai

AU - Chen, Fang Ping

AU - Chen, Chung Hwan

AU - Chang, Yin Fan

AU - Hung, Wei Chieh

AU - Han, Der Sheng

AU - Chan, Ding Cheng

AU - Tsai, Ching Chou

AU - Chen, I. Wen

AU - Chan, Wing P.

AU - Chang, Husan Jui

AU - Hwang, Jawl Shan

AU - Wu, Chih Hsing

PY - 2023

Y1 - 2023

N2 - Osteoporosis greatly increases the risk of fractures. Osteoporotic fractures negatively impact quality of life, increase the burden of care, and increase mortality. Taiwan is an area with a high prevalence of osteoporosis. This updated summary of guidelines has been developed by experts of the Taiwan Osteoporosis Association with the intention of reducing the risks of osteoporotic fractures and improving the quality of care for patients with osteoporosis. The updated guidelines compile the latest evidence to provide clinicians and other healthcare professionals with practical recommendations for the prevention, diagnosis, and management of osteoporosis under clinical settings in Taiwan.

AB - Osteoporosis greatly increases the risk of fractures. Osteoporotic fractures negatively impact quality of life, increase the burden of care, and increase mortality. Taiwan is an area with a high prevalence of osteoporosis. This updated summary of guidelines has been developed by experts of the Taiwan Osteoporosis Association with the intention of reducing the risks of osteoporotic fractures and improving the quality of care for patients with osteoporosis. The updated guidelines compile the latest evidence to provide clinicians and other healthcare professionals with practical recommendations for the prevention, diagnosis, and management of osteoporosis under clinical settings in Taiwan.

KW - Bone Density Conservation Agents/therapeutic use

KW - Humans

KW - Osteoporosis/complications

KW - Osteoporotic Fractures/prevention & control

KW - Quality of Life

KW - Secondary Prevention

KW - Taiwan/epidemiology

UR - http://www.scopus.com/inward/record.url?scp=85150389270&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85150389270&partnerID=8YFLogxK

U2 - 10.1016/j.jfma.2023.01.007

DO - 10.1016/j.jfma.2023.01.007

M3 - Review article

C2 - 36781371

AN - SCOPUS:85150389270

SN - 0929-6646

VL - 122

SP - S4-S13

JO - Journal of the Formosan Medical Association

JF - Journal of the Formosan Medical Association

IS - Suppl 1

ER -

Clinical practice guidelines for the prevention and treatment of osteoporosis in Taiwan: 2022 update

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this